Novavax Inc (NVAX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
| Sales | 201 | 29 | 21 | 70 | 194 |
| Gross Profit | 201 | 29 | 21 | 70 | 194 |
| Operating Expenses | 8,463 | 7,859 | 7,158 | 9,280 | 9,920 |
| Operating Income | -8,262 | -7,830 | -7,137 | -9,210 | -9,726 |
| Interest Expense | 19 | 326 | 437 | 0 | 0 |
| Other Income | 751 | -384 | -775 | 173 | -604 |
| Pre-tax Income | -7,530 | -8,540 | -8,349 | -9,037 | -10,330 |
| Net Income Continuous | -7,530 | -8,540 | -8,349 | -9,037 | -10,330 |
| Net Income Discontinuous | N/A | N/A | N/A | -505 | 2,488 |
| Net Income | $-7,530 | $-8,540 | $-8,349 | $-9,542 | $-7,842 |
| EPS Basic Total Ops | -1.60 | -2.00 | -2.40 | -2.20 | -2.40 |
| EPS Basic Continuous Ops | -1.63 | -2.01 | -2.43 | -1.80 | -3.20 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | -0.12 | 0.80 |
| EPS Diluted Total Ops | -1.60 | -2.00 | -2.40 | -2.20 | -2.40 |
| EPS Diluted Continuous Ops | -1.63 | -2.01 | -2.43 | -1.80 | -3.20 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | -0.12 | 0.80 |
| EBITDA(a) | $-7,959 | $-7,326 | $-6,676 | $-8,719 | $-9,413 |